Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to investigate efficacy and safety of 3 continuous combined regimens of Indivina in alleviation of vasomotor (estrogen deficiency) symptoms in women who are more than 1 year menopausal, by measuring the change in frequency and severity of moderate to severe vasomotor symptoms from baseline to Week 12 vasomotor (estrogen deficiency) symptoms using a self-assessed symptoms diary.
Critère d'inclusion
- Postmenopausal estrogen replacement regimen is the therapy of choice for the alleviation of climacteric symptoms. During the past few years, continuous-combined hormone replacement therapy (HRT) have become increasingly popular. Lower dose estrogen-progestogen combinations are likely to induce less bleeding disturbances and other adverse effects (AEs) and may therefore improve compliance and allow long-term treatment, necessary, e.g. for the prevention of postmenopausal bone loss